You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Govt places orders for 14.5 million doses of Covid-19 vaccines

The orders were placed with Serum Institute of India and Bharat Biotech

Topics
Coronavirus Vaccine | Coronavirus Tests

Press Trust of India  |  New Delhi 

coronavirus vaccine
A health worker shows COVID 19 vaccine Covaxin at R. G. Kar Medical College and hospital during COVID 19 vaccine run, in Kolkata

The government has placed orders for 1 crore (10 million) additional doses of Covishield from Serum Institute of India and 45 lakh (4.5 million) more doses of Covaxin from Bharat Biotech, officials of the two vaccine makers said on Tuesday.

India's COVID-19 vaccination drive was launched by Prime Minister Narendra Modi on January 16.

Serum Institute has received another order from the government for 10 million doses of Covishield, a company official said in response to a query.

The government had earlier placed a purchase order with Serum Institute of India (SII) for 1.1 crore doses of AstraZeneca-Oxford COVID-19 vaccine, Covishield.

When asked, a Bharat Biotech spokesperson said, "The company has received a letter of comfort from the Government of India to supply another 4.5 million (or 45 lakh) doses''.

The spokesperson also added that Bharat Biotech will also be exporting its COVID-19 vaccine, Covaxin, to Brazil and the United Arab Emirates.

The company is also likely to export the vaccine to the Philippines and other South Asian countries, the spokesperson said.

The government had earlier placed an order for 55 lakh doses of Covaxin from Bharat Biotech.

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, February 09 2021. 18:58 IST
RECOMMENDED FOR YOU